Mitsubishi Tanabe Pharma, Daiichi Sankyo enters licensing agreement for ALS treatment agent edaravone in Brazil
Posted on18 Sep 2019
Comments0
Mitsubishi Tanabe Pharma Corporation and Daiichi Sankyo announced that they have concluded a licensing agreement covering commercialization rights in Brazil for an... Read More
Kolon Life Science signs $438 out-licensing deal over arthritis drug Invossa
Kolon Life Science Inc. has signed 500 billion won ($438 million) out-licensing deal with Japan’s Mitsubishi Tanabe Pharma Corporation over Invossa, the... Read More
Sun Pharma signed a strategic distribution alliance with Mitsubishi Tanabe Pharma Corporation
Drug major Sun Pharma has announced initiation of a phased transfer of manufacturing and marketing rights of 14 brands, it acquired from... Read More
Regeneron Collaboration with Mitsubishi Tanabe Pharma for Investigational Pain Therapy Fasinumab in Asia
Regeneron Pharmaceuticals, Inc. today announced a collaboration with Mitsubishi Tanabe Pharma Corporation (MTPC) providing MTPC with exclusive development and commercial rights to... Read More